Management of FSGS
Steroid-resistant FSGS
Cyclosporin A vs placebo (Cattran et al. KI 1999)
CR/PR : 70% vs 4% (CSA much better)
MMF : Choi et al (n=18) but not controlled. New NIH multicenter RCT ongoing
Sirolimus : no evidence
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment